We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Connected Dose Inhaler Optimizes Respiratory Care

By HospiMedica International staff writers
Posted on 27 Dec 2016
A novel embedded metered dose inhaler (eMDI) enables improved adherence and real-time monitoring of asthma and chronic obstructive pulmonary disorder (COPD) patients.

The H&T Presspart (Blackburn, United Kingdom) eMDI is an intuitive, connected eMDI that tracks, records, and shares data on both preventive and relief medications, thus empowering patients in their self-care and improving adherence. More...
The connected data also aids real-time monitoring of medication use and symptom flare-ups by caregivers. Sensors within the inhaler track the date and time of medication use as well as the quality of delivery, which is recorded in onboard memory and also shared wirelessly Bluetooth, syncing with the BreatheSmart app.

The BreatheSmart app can thus provide users and caregivers customized reminders, real-time alerts and updates on medication usage, weekly and monthly summary reports which can be shared with family, caregivers and/or healthcare providers, and secure, automatic, realtime electronic medical record (EMR) integration. The medication utilization data from the eMDI can be merged with lung function data from the Cohero Health (New York, NY, USA) mSpirometer, a clinical grade handheld wireless spirometer that precisely measures critical lung function metrics.

Features of the device include embedded sensors to detect medication use and quality of medication administration, an embedded mechanical or electronic dose count and an intuitive and discrete design. Operation is consistent with standard puffer MDI operation, and is compatible with any canister. Battery life is consistent with the product shelf life, meaning that there is no need for replacement parts and no recharging or battery changes. In addition, the device incorporates a mechanical dose counter to allow pharmaceutical companies to transition current products to connected devices more easily.

“In designing the eMDI, our mission was to help pharmaceutical companies bring the best possible care to patients in an intuitive device in the fastest time and most cost-efficient way,” said Peter Schmelzer, CEO of H&T Presspart.

“We have thus combined the design of the world’s most widely used and established inhaler technology with the only respiratory platform that gives a complete and objective picture of how a patient is responding to treatment between reviews,” said Mellissa Manice, co-founder and CEO of Cohero Health.

Related Links:
H&T Presspart
Cohero Health

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.